Biotech Stocks On The Move

 | May 24, 2018 12:58AM ET

Many biotech stocks don’t trade on earnings (they don’t have any) but on expectations for future earnings potential. With ASCO right around the corner, we are starting to see some biotech stocks perking up on speculation of good news coming out of the conference. Also keep in mind that the biotech ETF, iShares Nasdaq Biotechnology (NASDAQ:IBB) is at a pivotal level right below its 200dma and if it manages to break out, we are likely to see numerous good trading opportunities in the sector.